<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00973791</url>
  </required_header>
  <id_info>
    <org_study_id>NJMU-08711MZ</org_study_id>
    <nct_id>NCT00973791</nct_id>
  </id_info>
  <brief_title>Fluid Management for Cesarean Section II</brief_title>
  <acronym>FMCS-II</acronym>
  <official_title>Fluid Management for Cesarean Section Undergoing Spinal Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nanjing Maternity and Child Health Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fluid management plays an essential role in cesarean section. In previous study (NCT00488111)
      the investigators found that prior-epidural anesthesia fluid management produced a more
      significant role in stabilizing the blood pressure and better prognosis after cesarean
      delivery than that of the posterior-anesthesia ones. Given epidural anesthesia has a time
      interval before reaching the best state of anesthesia, so the fluid management also has a
      relatively adequate time to resuscitation. In reality, spinal anesthesia is used popularly
      except for the epidural anesthesia, whereas spinal anesthesia would produce more significant
      fluctuation of the hemodynamics compared with the latter. Herein the investigators proposed
      whether the prior-spinal anesthesia fluid management also produced similar effect on
      hemodynamic characteristics to the epidural anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of hypotension</measure>
    <time_frame>Anesthesia begin (0 min) to 120 min after anesthesia</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recurrence of hypotension after ephedrine or phenylephrine</measure>
    <time_frame>Anesthesia begin (0 min) to 120 min after anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption of ephedrine and phenylephrine</measure>
    <time_frame>Anesthesia begin (0 min) to 120 min after anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total volume of colloid or crystalloid</measure>
    <time_frame>Fifteen minutes before anesthesia to 120 min after anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>One-min and 5-min Apgar scores</measure>
    <time_frame>The first and fifth minute after cesarean successful delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen saturation during hypotension</measure>
    <time_frame>Anesthesia begin (0 min) to 120 min after anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hypotension</measure>
    <time_frame>Anesthesia begin (0 min) to 120 min after anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low umbilical cord pH (artery &lt; 7.20)</measure>
    <time_frame>At the time of successful delivery (0 min)</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">860</enrollment>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Prior crystalloid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Crystalloid (Ringer's Lactate) was given before spinal anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Posterior crystalloid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Crystalloid (Ringer's Lactate) was given after spinal anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prior colloid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Colloid (6% hydroxyethyl starch) was given before spinal anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Posterior colloid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Colloid (6% hydroxyethyl starch) was given after spinal anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer's Lactate</intervention_name>
    <description>Ringer's Lactate 8 ml/kg was given intravenously before or after spinal anesthesia in cesarean section</description>
    <arm_group_label>Prior crystalloid</arm_group_label>
    <arm_group_label>Posterior crystalloid</arm_group_label>
    <other_name>Lactated Ringer's solution</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Six percent hydroxyethyl starch</intervention_name>
    <description>Hydroxyethyl starch (6%) was given before or after spinal anesthesia in cesarean section</description>
    <arm_group_label>Prior colloid</arm_group_label>
    <arm_group_label>Posterior colloid</arm_group_label>
    <other_name>HES/HAES</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  21-40 yr

          -  First time of delivery

          -  ASA status I-II

          -  No premature

          -  No genetic and infectious diseases

          -  Chinese

        Exclusion Criteria:

          -  &lt; 21 yr

          -  &gt; 40 yr

          -  Subjects with cardiac and pulmonary disorders

          -  Dislocation of placenta

          -  Pregnant hypertension

          -  Allergy to local anesthetics

          -  Unwilling to cooperation

          -  Need intraoperative administration of vascular active agents

          -  With significant delivery side effects
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>XiaoFeng Shen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Nanjing Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Affiliated Nanjing Maternity and Child Health Care Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2009</study_first_submitted>
  <study_first_submitted_qc>September 8, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2009</study_first_posted>
  <last_update_submitted>September 8, 2009</last_update_submitted>
  <last_update_submitted_qc>September 8, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2009</last_update_posted>
  <responsible_party>
    <name_title>XiaoFeng Shen</name_title>
    <organization>Nanjing Medical University</organization>
  </responsible_party>
  <keyword>Spinal anesthesia</keyword>
  <keyword>Fluid therapy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

